Our mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases.

Taking Big Steps

Visit our Online Magazine

MorphoSys' mission

MorphoSys mission is to make exceptional, innovative biopharmaceuticals to improve the lives of patients suffering from serious diseases. Our focus is on cancer. Innovative technologies and smart development strategies are central to our approach.

02/12/2020
MorphoSys' Licensee Announces Approval by the European Commission for...
01/12/2020
Thomas Biegi Joins MorphoSys as Head of Corporate Communications
11/11/2020
MorphoSys Reports Nine Months and Third Quarter 2020 Results
11/11/2020
MorphoSys and Cherry Biolabs Announce licensing of Hemibody Technology
11/11/2020
Xencor, MorphoSys and Incyte Enter into Global Development Collaboration...
04/11/2020
MorphoSys to Present Data on Tafasitamab at the ASH Virtual Annual Meeting...
04/11/2020
Invitation to MorphoSys' Third Quarter and First 9-Month 2020 Results...
27/10/2020
Ad hoc: MorphoSys AG Raises its Financial Guidance for the Full Year 2020
19/10/2020
MorphoSys' Licensee Janssen Receives CHMP Positive Opinion for...
13/10/2020
MorphoSys AG Successfully Places EUR 325 Million Convertible Bonds

November 17, 2020
Webcast
Stifel 2020 Virtual HC Conference

Full details